Epstein Secrets

-for-Ecuadorian-Intelligence-says-ex-UC-Global-manager> (11/12, Goodwin) reports that UC Global, "the company accused of spying on WikiLeaks founder Julian Assange in the Embassy of Ecuador," acted "on the orders of Ecuador's intelligence services." Michel Wallemacq, the firm's former head of operations, gave

receiving FDA emergency use authorization just this week, working to speed up the recovery in some of the most vulnerable patients." Correspondent Alex Perez said researchers took "the most powerful antibody from one of the first survivors and [are] using a synthetically-made version to fight the virus."

adorian Intelligence, Says Ex Manager. Computer Weekly (11/12, Goodwin) reports that UC Global, "the company accused of spying on WikiLeaks founder Julian Assange in the Embassy of Ecuador," acted "on the orders of Ecuador's intelligence services." Michel Wallemacq, the firm's former head of operations, gave "

t receiving FDA emergency use authorization just this week, working to speed up the recovery in some of the most vulnerable patients." Correspondent Alex Perez said EFTA00148420 researchers took "the most powerful antibody from one of the first survivors and [are] using a synthetically-made version to fi

nts of classified discovery and other issues." COUNTER-INTELLIGENCE Bail Hearing For Assange Set For Wednesday. Reuters (1/5, Holden) reports that Julian Assange, "who is currently being held in the top- security Belmarsh Prison in east London, will seek to be freed on bail at a hearing on Wednesday." On Mond

use call" with the knowledge that there was an arrest warrant for Blake at the time. On ABC World News TonightVi (1/5, story 3, 2:00, Muir, 7.66M), Alex Perez reported that Kenosha is "bracing for more protests after" Graveley's decision. The August 23 shooting took place "after police responded to a call

adorian Intelligence, Says Ex Manager. Computer Weekly (11/12, Goodwin) reports that UC Global, "the company accused of spying on WikiLeaks founder Julian Assange in the Embassy of Ecuador," acted "on the orders of Ecuador's intelligence services." Michel Wallemacq, the firm's former head of operations, gave "

t receiving FDA emergency use authorization just this week, working to speed up the recovery in some of the most vulnerable patients." Correspondent Alex Perez said researchers took "the most powerful antibody from one of the first survivors and [are] using a synthetically-made version to fight the virus."